Dapagliflozin 46708-0392-91
- Manufacturer
- Alembic Pharmaceuticals Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 6, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA211560
Need to source Dapagliflozin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dapagliflozin | 5 mg/1 |
Drug Class
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]Sodium-Glucose Cotransporter 2 Inhibitor [EPC]Sodium-Glucose Transporter 2 Inhibitors [MoA]
Selected Package
46708-0392-91Selected1000 TABLET, FILM COATED in 1 BOTTLE (46708-392-91)
Other packages for this product(1)
30 TABLET, FILM COATED in 1 BOTTLE (46708-392-30)